Asian perspectives on the recognition and management of levodopa 'wearing-off' in Parkinson's disease

被引:22
作者
Bhidayasiri, Roongroj [1 ,2 ]
Hattori, Nobutaka [3 ]
Jeon, Beomseok [4 ]
Chen, Rou-Shayn [5 ]
Lee, Moon Keen [6 ]
Bajwa, Jawad A. [7 ]
Mok, Vincent C. T. [8 ]
Zhang, Baorong [9 ]
Syamsudin, Thamrin [10 ]
Tan, Louis Chew Seng [11 ]
Jamora, Roland Dominic G. [12 ,13 ,14 ]
Pisarnpong, Apichart [15 ]
Poewe, Werner [16 ]
机构
[1] Chulalongkorn Univ, Fac Med, Chulalongkorn Ctr Excellence Parkinsons Dis & Rel, Bangkok 10330, Thailand
[2] King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Bangkok, Thailand
[3] Juntendo Univ, Sch Med, Tokyo 113, Japan
[4] Seoul Natl Univ, Seoul, South Korea
[5] Chang Gung Mem Hosp, Lingkou, Taiwan
[6] Sunway Med Ctr, Petaling Jaya 46150, Selangor, Malaysia
[7] Natl Inst Neurosci, Riyadh, Saudi Arabia
[8] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
[9] Zhejiang Univ, Sch Med, Dept Neurol, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China
[10] Natl Brain Ctr Hosp, Jakarta, Indonesia
[11] Natl Inst Neurosci, Singapore, Singapore
[12] Univ Philippines Manila, Dept Neurosci, Coll Med, Philippine Gen Hosp, Manila, Philippines
[13] St Lukes Med Ctr Quezon City & Global City, Movement Disorder Serv, Inst Neurosci, Quezon City, Philippines
[14] St Lukes Med Ctr Quezon City & Global City, Neurol Sect, Inst Neurosci, Quezon City, Philippines
[15] Bangkok Hosp, Dept Neurol, Bangkok, Thailand
[16] Med Univ Innsbruck, A-6020 Innsbruck, Austria
关键词
Arab; Asia; fluctuations; non-motor; Parkinson's disease; screening tools; wearing-off; CATECHOL-O-METHYLTRANSFERASE; DEEP BRAIN-STIMULATION; ROPINIROLE PROLONGED RELEASE; CARBIDOPA INTESTINAL GEL; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; MOTOR COMPLICATIONS; NONMOTOR FLUCTUATIONS; SUBCUTANEOUS APOMORPHINE; VAL158MET POLYMORPHISM;
D O I
10.1586/14737175.2015.1088783
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Most Parkinson's disease patients will receive levodopa therapy, and of these, the majority will develop some levodopa-induced complications. For many patients, the first complication to develop is the decline in the duration of therapeutic benefit of each levodopa dose, a phenomenon commonly termed wearing-off'. There is already extensive literature documenting the epidemiology and management of wearing-off in Parkinson's disease patients of western descent. However, data derived from these studies might not always apply to patients of Asian descent due to genetic variations, differences in co-morbidities or non-availability of certain drugs. This review summarizes the current literature regarding the epidemiology of wearing-off in Asian (including Arab) patients and discusses the management issues in the context of drug availability in Asia.
引用
收藏
页码:1285 / 1297
页数:13
相关论文
共 99 条
[1]   Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature [J].
Ahlskog, JE ;
Muenter, MD .
MOVEMENT DISORDERS, 2001, 16 (03) :448-458
[2]   One-year open-label study of entacapone in patients with advanced Parkinson disease [J].
Ahn, Tae-Beom ;
Im, Joo-Hyuk ;
Lee, Myoung Chong ;
Vim, Jae Woo ;
Lee, Won Yong ;
Jeon, Beom S. .
JOURNAL OF CLINICAL NEUROLOGY, 2007, 3 (02) :82-85
[3]  
[Anonymous], 2006, CLIN GUID CG35 PARK
[4]   Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome [J].
Antonini, Angelo ;
Isaias, Ioannis U. ;
Canesi, Margherita ;
Zibetti, Maurizio ;
Mancini, Francesca ;
Manfredi, Luigi ;
Dal Fante, Marco ;
Lopiano, Leonardo ;
Pezzoli, Gianni .
MOVEMENT DISORDERS, 2007, 22 (08) :1145-1149
[5]   Wearing-Off Scales in Parkinson's Disease: Critique and Recommendations [J].
Antonini, Angelo ;
Martinez-Martin, Pablo ;
Chaudhuri, Ray K. ;
Merello, Marcelo ;
Hauser, Robert ;
Katzenschlager, Regina ;
Odin, Per ;
Stacy, Mark ;
Stocchi, Fabrizio ;
Poewe, Werner ;
Rascol, Oliver ;
Sampaio, Cristina ;
Schrag, Anette ;
Stebbins, Glenn T. ;
Goetz, Christopher G. .
MOVEMENT DISORDERS, 2011, 26 (12) :2169-2175
[6]   A reassessment of risks and benefits of dopamine agonists in Parkinson's disease [J].
Antonini, Angelo ;
Tolosa, Eduardo ;
Mizuno, Yoshikuni ;
Yamamoto, Mitsutoshi ;
Poewe, Werner H. .
LANCET NEUROLOGY, 2009, 8 (10) :929-937
[7]   Clinical Spectrum of Levodopa-Induced Complications [J].
Aquino, Camila Catherine ;
Fox, Susan H. .
MOVEMENT DISORDERS, 2015, 30 (01) :80-89
[8]   Does WOQ-9 help to recognize symptoms of non-motor wearing-off in Parkinson's disease? [J].
Bares, Martin ;
Rektorova, Irena ;
Jech, Robert ;
Farnikova, Katerina ;
Roth, Jan ;
Ruzicka, Evzen ;
Kanovsky, Petr ;
Rektor, Ivan ;
Pavlik, Tomas ;
Uhlirova, Leona ;
Vydlak, Jaroslav .
JOURNAL OF NEURAL TRANSMISSION, 2012, 119 (03) :373-380
[9]   Parkinson's disease in Arabs: A systematic review [J].
Benamer, Hani T. S. ;
de Silva, Rajith ;
Siddiqui, Khurram A. ;
Grosset, Donald G. .
MOVEMENT DISORDERS, 2008, 23 (09) :1205-1210
[10]   Motor complications in Parkinson disease: Clinical manifestations and management [J].
Bhidayasir, Roongroj ;
Truong, Daniel D. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 266 (1-2) :204-215